Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment
批准号:
8088220
负责人:
Lichun Lu
金额:
$42.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2013-03-31
关键词:
AbbreviationsAchievementActivities of Daily LivingAddressAffectApplications GrantsBiocompatible MaterialsBraces-Orthopedic appliancesCadaverCarrying CapacitiesClinicalDataDefectDevelopmentDiagnosisDiagnosticDiseaseDisseminated Malignant NeoplasmEvaluationExcisionFailureFamilyFractureGoalsHome environmentImage AnalysisIn VitroInjectableInjuryLength of StayLifeMalignant NeoplasmsMechanicsMethodologyMethodsModelingNatureNeoplasm MetastasisNerve compression syndromeNeurologicOperative Surgical ProceduresPainParalysedPathologicPatient CarePatientsPhysiologicalPositioning AttributePropertyRecommendationRecoveryRehabilitation therapyResearchResidual stateRiskScanningShapesSheepSorting - Cell MovementSpinalSpinal CordSpinal FracturesSpinal nerve structureSystemTechniquesTemperatureTimeTissuesTranslationsTumor TissueValidationVertebral columnWeight-Bearing stateX-Ray Computed Tomographybasebone strengthclinical practicecomputer programcomputerizeddensitydesignexperienceheat injuryin vivoindexingminimally invasivenoveloperationpolymerizationpre-clinicalprogramspublic health relevancereconstitutionreconstructionspine bone structuretheoriestumorvalidation studies
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The identification of cancer metastases to the bony vertebral column obligates the treating clinician to make a surgical decision. The consequences of that decision for the patient are significant whether the recommendation is for surgical or non-surgical treatment. If the spine is deemed unstable and at risk for fracture, then the patient will undergo a major spinal operation, and will often spend much of their remaining life recuperating from it. Conversely, the patient whose spine is deemed stable and receives non-surgical treatment risks fracture and possible paralysis if the stability analysis was incorrect. In addition, the metastatic disease usually progresses, and the stability analysis must be repeated at intervals throughout the disease course. The spinal stability decision is empirical and can be inaccurate, even when done by experienced spinal clinicians. This proposal addresses both the stability decision and, for those patients deemed at risk for fracture, the nature of the treatment. Aim 1 describes the development of an automated program that analyzes spinal computerized tomography scans, and calculates the residual load carrying capacity of the affected vertebra. Aim 2 optimizes novel injectable materials to restore the load carrying capacity of the vertebra in a minimally invasive manner, thus decreasing time in recovery and rehabilitation from major spine surgery. Successful achievement of this aim would offer an alternative to open surgery for many of these patients, thus decreasing their rehabilitation time and increasing their family time. Aim 3 addresses validation of both the automated spinal stability analysis and the minimally invasive spinal reconstruction. These in vitro and in vivo Aim 3 preclinical validation studies are requisite steps to position both the Aim 1 automated diagnostic methodology and the Aim 2 minimally invasive surgical treatment methodology closer to the goal of translation to clinical practice.
Public Health Relevance Statement (provided by applicant): The computerized spinal stability assessment, for patients who have cancer that has spread to their spine, will offer more accurate diagnosis of the need for spine surgery to the patients, and with a much greater likelihood that the patients and their families can get the evaluation done near their home, saving them time, expense, and inconvenience. The recommendation for non-surgical treatment will be made with increased assurance that the risk of a spine fracture is low. Those patients, who do need surgery, will often chose minimally invasive surgical techniques that will shorten their hospital stay and allow them to return home to their families.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion
-
批准号:10089684
-
项目类别:
-
资助金额:$5.05万
-
财政年份:2019
-
负责人:Lichun Lu
-
依托单位:
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion
-
批准号:9908051
-
项目类别:
-
资助金额:$52.72万
-
财政年份:2019
-
负责人:Lichun Lu
-
依托单位:
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion
-
批准号:10364656
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2019
-
负责人:Lichun Lu
-
依托单位:
Injectable and Moldable Composite Bone Scaffolds for Spinal Fusion
-
批准号:10444098
-
项目类别:
-
资助金额:$6.73万
-
财政年份:2019
-
负责人:Lichun Lu
-
依托单位:
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment
-
批准号:7796565
-
项目类别:
-
资助金额:$41.49万
-
财政年份:2008
-
负责人:Lichun Lu
-
依托单位:
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master
-
批准号:8963947
-
项目类别:
-
资助金额:$46.93万
-
财政年份:2008
-
负责人:Lichun Lu
-
依托单位:
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment
-
批准号:7428992
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2008
-
负责人:Lichun Lu
-
依托单位:
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment
-
批准号:8244358
-
项目类别:
-
资助金额:$46.92万
-
财政年份:2008
-
负责人:Lichun Lu
-
依托单位:
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment
-
批准号:7599113
-
项目类别:
-
资助金额:$47.69万
-
财政年份:2008
-
负责人:Lichun Lu
-
依托单位:
Metastatic Spine Tumors: Minimally Invasive Fracture Risk Analysis and Treatment - Master
-
批准号:10585673
-
项目类别:
-
资助金额:$41.44万
-
财政年份:2008
-
负责人:Lichun Lu
-
依托单位:
Injectable and Preformed Osteoinductive Biodegradable Composites
-
批准号:8104720
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2003
-
负责人:Lichun Lu
-
依托单位:
Injectable and Preformed Osteoinductive Biodegradable Composites
-
批准号:8627969
-
项目类别:
-
资助金额:$45.99万
-
财政年份:2003
-
负责人:Lichun Lu
-
依托单位:
Injectable and Preformed Osteoinductive Biodegradable Composites
-
批准号:8261873
-
项目类别:
-
资助金额:$57.69万
-
财政年份:2003
-
负责人:Lichun Lu
-
依托单位:
Injectable and Preformed Osteoinductive Biodegradable Composites
-
批准号:8440796
-
项目类别:
-
资助金额:$39.37万
-
财政年份:2003
-
负责人:Lichun Lu
-
依托单位:
海外基金